News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Apogee to Present phase 1 Clinical Trial Results at the 2013 Molecular Targets and Cancer Therapeutics Meeting



10/1/2013 10:04:47 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Apogee will present interim data from the first-in-human trial of ABC294640 entitled “A Phase I, Open-Label, Dose-Escalation Safety, Pharmacokinetic and Pharmacodynamic Study of ABC294640 in Patients with Advanced Solid Tumors” at the Molecular Targets and Cancer Therapeutics meeting in Boston on Tuesday, October 22.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES